Trial Profile
Randomized, Single-blind Comparison of Three Commercially Available Botulinum Neuromodulators in the Management of Facial Synkinesis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Aug 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Facial asymmetry; Facial nerve diseases; Paresis
- Focus Therapeutic Use
- 14 Feb 2017 New trial record